California State Teachers Retirement System (CalSTRS)’s Taysha Gene Therapies TSHA Stock Holding History
Bought
Maintained
Sold
Other funds holding TSHA
RCM
ACA
VPC
RI
VCM
California State Teachers Retirement System (CalSTRS)'s TSHA Position: Q1 2026 in Review
California State Teachers Retirement System (CalSTRS) reduced its Taysha Gene Therapies (TSHA) stake by 1.2% in Q1 2026, selling an estimated $7.66K and leaving 136,933 shares worth $612K. The position accounts for ﹤0.01% of the portfolio, ranked #1992.
California State Teachers Retirement System (CalSTRS) first reported a position in TSHA in Q4 2020 and has held it in 14 quarters since. The position peaked at $762K in Q4 2025. 191 funds tracked by Wall St. Rank hold TSHA as of Q1 2026.
- California State Teachers Retirement System (CalSTRS) held 136,933 shares of Taysha Gene Therapies worth $612K as of Q1 2026.
- California State Teachers Retirement System (CalSTRS) sold 1,647 Taysha Gene Therapies shares in Q1 2026, an estimated $7.66K.
- Taysha Gene Therapies made up ﹤0.01% of California State Teachers Retirement System (CalSTRS)'s portfolio in Q1 2026, its #1992 holding.
- California State Teachers Retirement System (CalSTRS) first reported a position in Taysha Gene Therapies in Q4 2020 and has held it in 14 quarters since.
- California State Teachers Retirement System (CalSTRS)'s Taysha Gene Therapies position peaked at $762K in Q4 2025.
- 191 funds tracked by Wall St. Rank held Taysha Gene Therapies as of Q1 2026.
Based on California State Teachers Retirement System (CalSTRS)'s 13F filing for Q1 2026, filed 18 May 2026.